Over 98% of cases of the fragile X syndrome are due to a dynamic repeat-sequence mutation in the FMR1 gene. The normal, stable repeat sequence consists of CGG triplet repeats interrupted by single AGG trinucleotide sequences. The initial mutation that predisposes the repeat region to become unstable is due to any mechanism that results in an increased number of uninterrupted CGG repeats in the 3' region. Factors that affect those mechanisms and factors affecting the subsequent hyper-expansion, eventually leading to the silencing of the gene and consequent mental retardation, have yet to be identified. However, there are intriguing preliminary data that suggest such factors exist. We propose to combine genetic epidemiological and population genetic approaches to characterize possible mechanisms and factors that influence both the initial mutation and expansion processes. At a population level, we will examine the haplotype background of FMR1 alleles using both microsatellite and single-base change polymorphic markers in a large Caucasian, a large African-American and smaller African, Asian and Native American populations to determine the history of the mutation and determine if unique mutation pathways can be defined. To test hypotheses resulting from these studies, sperm from males with specific repeat sequence structures and haplotype backgrounds will be used as an """"""""experimental"""""""" system to examine possible mutation processes and their rates. In addition, premutation carrier parent-carrier offspring transmissions ascertained from fragile X families will be used to examine factors that affected the expansion process. Finally, biological processes suggested by these data will be theoretically modeled and validated by empirical data. The fate and impact of the fragile X mutation on the general population will be examined using such methods. The results obtained from this detailed analysis of the dynamics of the mutation process will be an important preliminary step to determine the molecular mechanism of this sever mental retardation syndrome.

Project Start
1997-09-10
Project End
1998-07-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Spath, Marian A; Feuth, Ton B; Smits, Arie P T et al. (2011) Predictors and risk model development for menopausal age in fragile X premutation carriers. Genet Med 13:643-50
Spath, M A; Feuth, T B; Allen, E G et al. (2011) Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers. Hum Reprod 26:2185-91
Wang, Houping; Dictenberg, Jason B; Ku, Li et al. (2008) Dynamic association of the fragile X mental retardation protein as a messenger ribonucleoprotein between microtubules and polyribosomes. Mol Biol Cell 19:105-14
Allen, E G; Sullivan, A K; Marcus, M et al. (2007) Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod 22:2142-52
Anido, Aimee; Carlson, Lisa M; Sherman, Stephanie L (2007) Attitudes toward fragile X mutation carrier testing from women identified in a general population survey. J Genet Couns 16:97-104
Li, Wen; Xia, Jin-tang; Feng, Yue (2006) Microtubule stability and MAP1B upregulation control neuritogenesis in CAD cells. Acta Pharmacol Sin 27:1119-26
Smith, Karen T; Nicholls, Robert D; Reines, Daniel (2006) The gene encoding the fragile X RNA-binding protein is controlled by nuclear respiratory factor 2 and the CREB family of transcription factors. Nucleic Acids Res 34:1205-15
Garber, Kathryn; Smith, Karen T; Reines, Danny et al. (2006) Transcription, translation and fragile X syndrome. Curr Opin Genet Dev 16:270-5
Anido, Aimee; Carlson, Lisa M; Taft, Lisa et al. (2005) Women's attitudes toward testing for fragile X carrier status: a qualitative analysis. J Genet Couns 14:295-306
Nakamoto, Mika; Jin, Peng; O'Donnell, William T et al. (2005) Physiological identification of human transcripts translationally regulated by a specific microRNA. Hum Mol Genet 14:3813-21

Showing the most recent 10 out of 45 publications